-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Rare Pediatric Disease Designation to Atossa Therapeutics' (Z)-Endoxifen for Duchenne Muscular Dystrophy

Reuters·12/11/2025 13:01:57

Please log in to view news